Affordable Access

The current status of erythromycin, kanamycin, novobiocin, oleandomycin, ristocetin, and vancomycin, with particular reference to their use in staphylococcal disease; panel discussion.

Authors
Type
Published Article
Journal
Antibiotics annual
Publication Date
Volume
6
Pages
1051–1072
Identifiers
PMID: 13637882
Source
Medline
Keywords
License
Unknown

Statistics

Seen <100 times